Efficacy and safety of ramosetron versus ondansetron for postoperative nausea and vomiting after general anesthesia: a meta-analysis of randomized clinical trials.

Drug Des Devel Ther · 2015 · PMC4410833 · PMID 25960637

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

did not reach statistical significanceP =0.06so close (0.05 < p ≤ 0.1)

However, ramosetron had a tendency to be more effective than ondansetron during the 24–48-hour time period after surgery, but this effect did not reach statistical significance (RR 0.60, 95% CI 0.36–1.01; P =0.06), ( Figure 2 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.